Male androgenetic alopecia male androgenetic alopecia, pattern hair loss, topical finasteride
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Androgenetic alopecia with mild to moderate severity
Exclusion criteria
Exclusion criteria: Allergic history to finasteride or minoxidil, use of topical medications for hair loss during previous 3 months, use of oral medications for hair loss during previous 6 months, use of light/laser therapy or PRP for hair loss during previous 3 months, hair transplantation, significant scalp diseases, history of depression or suicidal idea.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from baseline in hair density using videodermoscopy 24 weeks micrographs from videodermoscopy | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall clinical changes from baseline 24 weeks paired global photographs,Change from baseline in serum DHT 24 weeks ELISA test for serum DHT,patient satisfaction 24 weeks 10-point visual analog scale,adverse events 24 weeks interview, questionnaire | — |
Countries
Thailand
Contacts
Srinakharinwirot University